This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Divergent clonal selection dominates medulloblastoma at recurrence.
Nature · 2016
Latest funding
- $300,000
An interactive toolbox for multi-omics gene prioritisation and pathway enrichment
CIHR · 2024 · Nominated PI
- $1,201,050
Discovery and functional validation of non-coding cancer driver mutations for biological insights and target discovery
CIHR · 2024 · Nominated PI
- $80,000
Integrative pathway analysis of multi-omics datasets
NSERC · 2023 · Principal investigator
1 publications.
Divergent clonal selection dominates medulloblastoma at recurrence.
Morrissy AS, Garzia L, Shih DJ, Zuyderduyn S, Huang X, Skowron P, Remke M, Cavalli FM, Ramaswamy V, Lindsay PE, Jelveh S, Donovan LK, Wang X, Luu B, Zayne K, Li Y, Mayoh C, Thiessen N, Mercier E, Mungall KL, Ma Y, Tse K, Zeng T, Shumansky K, Roth AJ, Shah S, Farooq H, Kijima N, Holgado BL, Lee JJ, Matan-Lithwick S, Liu J, Mack SC, Manno A, Michealraj KA, Nor C, Peacock J, Qin L, Reimand J, Rolider A, Thompson YY, Wu X, Pugh T, Ally A, Bilenky M, Butterfield YS, Carlsen R, Cheng Y, Chuah E, Corbett RD, Dhalla N, He A, Lee D, Li HI, Long W, Mayo M, Plettner P, Qian JQ, Schein JE, Tam A, Wong T, Birol I, Zhao Y, Faria CC, Pimentel J, Nunes S, Shalaby T, Grotzer M, Pollack IF, Hamilton RL, Li XN, Bendel AE, Fults DW, Walter AW, Kumabe T, Tominaga T, Collins VP, Cho YJ, Hoffman C, Lyden D, Wisoff JH, Garvin JH, Stearns DS, Massimi L, Schüller U, Sterba J, Zitterbart K, Puget S, Ayrault O, Dunn SE, Tirapelli DP, Carlotti CG, Wheeler H, Hallahan AR, Ingram W, MacDonald TJ, Olson JJ, Van Meir EG, Lee JY, Wang KC, Kim SK, Cho BK, Pietsch T, Fleischhack G, Tippelt S, Ra YS, Bailey S, Lindsey JC, Clifford SC, Eberhart CG, Cooper MK, Packer RJ, Massimino M, Garre ML, Bartels U, Tabori U, Hawkins CE, Dirks P, Bouffet E, Rutka JT, Wechsler-Reya RJ, Weiss WA, Collier LS, Dupuy AJ, Korshunov A, Jones DT, Kool M, Northcott PA, Pfister SM, Largaespada DA, Mungall AJ, Moore RA, Jabado N, Bader GD, Jones SJ, Malkin D, Marra MA, Taylor MD
An interactive toolbox for multi-omics gene prioritisation and pathway enrichment
Principal investigators: Reimand, Jüri
Keywords: Bioinformatics; Biomarkers; Data Fusion; Data Integration; Data Visualisation; Gene Prioritisation; Multi-Omics; Pathway Enrichment Analysis; Target Discovery
Discovery and functional validation of non-coding cancer driver mutations for biological insights and target discovery
Principal investigators: Reimand, Jüri
Keywords: Biomarkers; Cancer Genomics; Crispr Screens; Driver Mutations; Genome Editing; Machine Learning; Non-Coding Genome; Oncogenes; Preclinical Study; Tumor Suppressors
Integrative pathway analysis of multi-omics datasets
Principal investigators: Reimand, Jüri
Keywords: Cell signalling; Computational biology; Data integration; Data visualisation; Gene regulation; Genomics; Network analysis; Pathway enrichment analysis; Proteomics; Transcriptomics
Systematic study of regional mutation rates in multiple cancer types to identify the role of chemotherapies in metastasis
Principal investigators: Reimand, Jüri
Keywords: Cancer Genomics; Chemotherapy; Machine Learning; Metastasis; Somatic Mutations; Whole Genome Sequencing
Predicting antidepressant remission in late-life depression using polygenic risk scoring and machine learning models
Principal investigators: Mueller, Daniel J; Reimand, Jüri
Keywords: Antidepressants; Genetics; Late-Life Depression; Machine Learning; Pharmacogenetics; Polygenic Risk Scores; Predictive Modelling; Treatment Response
Deciphering recurrence of glioblastoma for precision medicine using multi-omics data integration
Principal investigators: Reimand, Jüri
Keywords: Bioinformatics; Cancer Driver Mutations; Data Integration; Glioblastoma; Proteogenomics; Recurrence And Metastasis; Sub-Clonal Reconstruction; Tumor Evolution; Whole Genome Sequencing
Discovery of non-coding driver mutations and pathways in thousands of whole cancer genomes using gene regulatory and long-range chromatin interactions
Principal investigators: Reimand, Jüri
Keywords: Biomarker Discovery; Cancer Driver Genes; Chromatin Interactions; Epigenomics; Functional Validation; Meta-Analysis; Pan-Cancer; Pathway And Network Analysis; Variant Interpretation; Whole Genome Sequencing
Predicting the Impact of Somatic Structural Variation in Cancer Whole Genomes
Principal investigators: Zhu, Helen
Keywords: Bioinformatics; Cancer; Computer Science; Genomics; Software Development; Statistics & Data Science
Pathway Maps of Transcription Factors
Principal investigators: Reimand, Jüri
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Pediatrics
- Department of Paediatrics
- Genome Sciences Centre
- Department of Medical Biophysics
- Genetics and Genome Biology
- Developmental Stem Cell Biology
- Other
Co-authors at University of Toronto, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Ute Bartels
Faculty
1 shared papers, latest 2016
Livia Garzia
Faculty
1 shared papers, latest 2016
Uri Tabori
Genetics and Genome Biology
1 shared papers, latest 2016
Nada Jabado
Pediatrics
1 shared papers, latest 2016
David Malkin
Pediatrics
1 shared papers, latest 2016
Sohrab Shah
Faculty
1 shared papers, latest 2016
Inanc Birol
Genome Sciences Centre
1 shared papers, latest 2016
Trevor Pugh
Department of Medical Biophysics
1 shared papers, latest 2016
Xi Huang
Faculty
1 shared papers, latest 2016
Vijay Ramaswamy
Developmental Stem Cell Biology
1 shared papers, latest 2016
Eric Bouffet
Department of Paediatrics
1 shared papers, latest 2016
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.